Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STITCH: Simplified Treatment Algorithm for Hypertension
NCT00129909Phase 4Completed
- Sponsor
- Western University
- Start
- May 2005
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of quinapril and hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Western University. Primary endpoint: Proportion of subjects treated to target (SBP <140 mmHg and DBP <90 mmHg) at 6 months. Started May 2005; status: completed.
02
Drugs
quinaprilhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00129909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00129909.